Immunology
-
Anti-SARS-CoV-2 swine glyco-humanized polyclonal antibody XAV-19 retains neutralizing activity against SARS-CoV-2 B.1.1.529 (Omicron)
This article has 15 authors:Reviewed by ScreenIT
-
Mutations of SARS-CoV-2 variants of concern escaping Spike-specific T cells
This article has 15 authors:Reviewed by ScreenIT
-
Design of immunogens for eliciting antibody responses that may protect against SARS-CoV-2 variants
This article has 2 authors:Reviewed by ScreenIT
-
Forecasted Trends of the New COVID-19 Epidemic Due to the Omicron Variant in Thailand, 2022
This article has 5 authors:Reviewed by ScreenIT
-
Host chitinase 3-like-1 is a universal therapeutic target for SARS-CoV-2 viral variants in COVID-19
This article has 7 authors:This article has been curated by 1 group: -
Extensive age-dependent loss of antibody diversity in naturally short-lived turquoise killifish
This article has 5 authors:This article has been curated by 1 group:Reviewed by eLife
-
Fracture healing is delayed in the absence of gasdermin-interleukin-1 signaling
This article has 13 authors:This article has been curated by 1 group:Reviewed by eLife
-
Broadly recognized, cross-reactive SARS-CoV-2 CD4 T cell epitopes are highly conserved across human coronaviruses and presented by common HLA alleles
This article has 11 authors:Reviewed by ScreenIT
-
Macrophage network dynamics depend on haptokinesis for optimal local surveillance
This article has 2 authors:This article has been curated by 1 group:Reviewed by eLife
-
Longitudinal Assessment of SARS-CoV-2 Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multi-Cytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity
This article has 19 authors:Reviewed by ScreenIT